SU803: Pharmacology B
Study Board of Science
Teaching language: Danish or English depending on the teacher
EKA: N810006112, N810006102
Assessment: Second examiner: None, Second examiner: External
Grading: Pass/Fail, 7-point grading scale
Offered in: Odense
Offered in: Autumn
Level: Master
STADS ID (UVA): N810006101
ECTS value: 5
Date of Approval: 31-03-2022
Duration: 1 semester
Version: Approved - active
Comment
Entry requirements
Academic preconditions
Students taking the course are expected to have basic knowledge of molecular biology, biochemistry, physiology and neurobiology.
Course introduction
The aim of the course is to enable the student to understand rational pharmacotherapy and modern drug discovery.
The course builds on the knowledge acquired in the courses SU502: Medical Physiology and SU503: Pharmacology A, and refers to the courses SU802: Medical neurobiology and SU811: Molecular Pathophysiology. The course gives an academic basis for studying pharmacology in relationship to modern technology and health and apply this in future biomedical research.
In relation to the competence profile of the degree it is the explicit focus of the course to:
- Give the competence to critically, summarise and present a pharmalogical topic
- Give skills to design and interpret pharmacological research experiments
- Give knowledge and understanding of the interrelationship between pathophysiological mechanisms and drug actions.
Expected learning outcome
The learning objectives of the course are that the student demonstrates the ability to:
- understand and apply basic and novel mechanisms of action of drugs and their primary and secondary targets in relation to treatment and prevention of major diseases.
- design experimental approaches and interpret experimental observations of pharmacological problems in particular and biomedical subjects in general.
- apply pharmacological knowledge to e.g. cardiovascular, renal, pulmonary, malignant and central nervous system diseases and their drug treatment.
- apply knowledge of risk factors to rational drug discovery, development and treatment.
Content
The following main topics are contained in the course:
- New techniques and modern molecular insights in drug receptors as main drug targets in relationship to acute and chronic drug treatment.
- Relationships between pathophysiological mechanisms and drug discovery and applications.
- Elaboration of specific examples of new classes of drugs for unmet needs and old drugs finding new applications in the cardiovascular, metabolic and central nervous systems.
Literature
Rang&Dale’s Pharmacology, 9th edition.
See itslearning for syllabus lists and additional literature references.
See itslearning for syllabus lists and additional literature references.
Examination regulations
Prerequisite examination a)
Timing
Autumn
Tests
Oral presentation
EKA
N810006112
Assessment
Second examiner: None
Grading
Pass/Fail
Identification
Full name and SDU username
Language
Normally, the same as teaching language
Examination aids
To be announced during the course
ECTS value
0
Additional information
The prerequisite examination is a prerequisite for participation in exam element a)
Exam element a)
Timing
January
Prerequisites
Type | Prerequisite name | Prerequisite course |
---|---|---|
Examination part | Prerequisite examination a) | N810006101, SU803: Pharmacology B |
Tests
Written exam
EKA
N810006102
Assessment
Second examiner: External
Grading
7-point grading scale
Identification
Student Identification Card
Language
Normally, the same as teaching language
Duration
4 hours
Examination aids
The exam is without aids. However, standard build in calculator in Windows/MAC are allowed. It is also allowed to use Maple, Mathematica, Mathcad, MathLab, GeoGebra Apps, R, R-Studio, CAS TI-Nspire, Ms Excel og LibreOffice Calc. WordMat is allowed but not recommended. Use of WordMat is at your own risk and no support is provided for errors caused by the program.
The Internet is not allowed during the exam. However, you may visit the system "DE-Digital Exam"
ECTS value
5
Additional information
Reexamination in the same exam period or immediately thereafter.
Indicative number of lessons
Teaching Method
At the faculty of science, teaching is organized after the three-phase model ie. intro, training and study phase.
The intro phase consists of lectures with activating teaching methods. A short introduction to the course topics is given, and competencies are gained through lectures, discussion and student presentations.
During the training phase students acquire competencies within pharmacology. The students work independently with the study of relevant literature in order to be able to present and discuss a theme within subject areas, which are not covered in lectures.
In the study phase, students are expected to work independently with the syllabus. Students are expected to use part of the study phase to read up on skills from the training phase and reserve a part for exam reading.
Activities during the study phase:
- Self-study of syllabus
- Independent professional understanding of knowledge gained during the intro and training phases
- Exam preparation
Teacher responsible
Name | Department | |
---|---|---|
Ulrike Muscha Steckelings | usteckelings@health.sdu.dk | Kardiovaskulær & Renalforskning |
Timetable
Administrative Unit
Team at Educational Law & Registration
Offered in
Recommended course of study
Profile | Education | Semester | Offer period |
---|---|---|---|
MSc in major Biomedicine - registration 1 september 2020 and 2021 | | Odense | 1 | E22 |
MSc in major Biomedicine - registration 1 september 2021 | | Odense | 1 | E23 |
MSc in major Biomedicine - registration 1 september 2022 | | Odense | 1 | E22 |
MSc in major Biomedicine - registration 1 september 2022 and 2023 | | Odense | 1 | E23 |
Transition rules
Transitional arrangements describe how a course replaces another course when changes are made to the course of study.
If a transitional arrangement has been made for a course, it will be stated in the list.
See transitional arrangements for all courses at the Faculty of Science.